188 related articles for article (PubMed ID: 32436394)
1. Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice.
Delli Pizzi A; Mastrodicasa D; Cianci R; Serafini FL; Mincuzzi E; Di Fabio F; Giammarino A; Mannetta G; Basilico R; Caulo M
Can Assoc Radiol J; 2021 Nov; 72(4):714-727. PubMed ID: 32436394
[TBL] [Abstract][Full Text] [Related]
2. Liver Imaging Reporting and Data System (LI-RADS) v2018: Review of the CT/MRI Diagnostic Categories.
Kanmaniraja D; Dellacerra G; Holder J; Erlichman D; Chernyak V
Can Assoc Radiol J; 2021 Feb; 72(1):142-149. PubMed ID: 32063008
[TBL] [Abstract][Full Text] [Related]
3. LI-RADS: Past, Present, and Future, From the
Marks RM; Masch WR; Chernyak V
AJR Am J Roentgenol; 2021 Feb; 216(2):295-304. PubMed ID: 33052720
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.
Ren AH; Zhao PF; Yang DW; Du JB; Wang ZC; Yang ZH
J Magn Reson Imaging; 2019 Sep; 50(3):746-755. PubMed ID: 30648327
[TBL] [Abstract][Full Text] [Related]
5. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.
Elsayes KM; Kielar AZ; Elmohr MM; Chernyak V; Masch WR; Furlan A; Marks RM; Cruite I; Fowler KJ; Tang A; Bashir MR; Hecht EM; Kamaya A; Jambhekar K; Kamath A; Arora S; Bijan B; Ash R; Kassam Z; Chaudhry H; McGahan JP; Yacoub JH; McInnes M; Fung AW; Shanbhogue K; Lee J; Deshmukh S; Horvat N; Mitchell DG; Do RKG; Surabhi VR; Szklaruk J; Sirlin CB
Abdom Radiol (NY); 2018 Oct; 43(10):2625-2642. PubMed ID: 30155697
[TBL] [Abstract][Full Text] [Related]
6. LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.
Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
Radiology; 2019 Sep; 292(3):655-663. PubMed ID: 31310175
[TBL] [Abstract][Full Text] [Related]
7. CT/MR LI-RADS 2018: clinical implications and management recommendations.
Kamath A; Roudenko A; Hecht E; Sirlin C; Chernyak V; Fowler K; Mitchell DG
Abdom Radiol (NY); 2019 Apr; 44(4):1306-1322. PubMed ID: 30671612
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
[TBL] [Abstract][Full Text] [Related]
11. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
12. LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.
Shropshire EL; Chaudhry M; Miller CM; Allen BC; Bozdogan E; Cardona DM; King LY; Janas GL; Do RK; Kim CY; Ronald J; Bashir MR
Radiology; 2019 Jul; 292(1):226-234. PubMed ID: 31038409
[TBL] [Abstract][Full Text] [Related]
13. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.
Chernyak V; Fowler KJ; Kamaya A; Kielar AZ; Elsayes KM; Bashir MR; Kono Y; Do RK; Mitchell DG; Singal AG; Tang A; Sirlin CB
Radiology; 2018 Dec; 289(3):816-830. PubMed ID: 30251931
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma.
Li S; Zhou L; Chen R; Chen Y; Niu Z; Qian L; Fang Y; Xu L; Xu H; Zhang L
Clin Radiol; 2021 Feb; 76(2):161.e1-161.e10. PubMed ID: 33198943
[TBL] [Abstract][Full Text] [Related]
15. Does quantitative assessment of arterial phase hyperenhancement and washout improve LI-RADS v2018-based classification of liver lesions?
Stocker D; Becker AS; Barth BK; Skawran S; Kaniewska M; Fischer MA; Donati O; Reiner CS
Eur Radiol; 2020 May; 30(5):2922-2933. PubMed ID: 32020398
[TBL] [Abstract][Full Text] [Related]
16. The interreader agreement and validation of contrast-enhanced ultrasound liver imaging reporting and data system.
Li J; Ling W; Chen S; Ma L; Yang L; Lu Q; Luo Y
Eur J Radiol; 2019 Nov; 120():108685. PubMed ID: 31606712
[TBL] [Abstract][Full Text] [Related]
17. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
18. Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma.
Kierans AS; Song C; Gavlin A; Roudenko A; Lu L; Askin G; Hecht EM
AJR Am J Roentgenol; 2020 Nov; 215(5):1085-1092. PubMed ID: 32877248
[No Abstract] [Full Text] [Related]
19. Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018.
Ludwig DR; Fraum TJ; Cannella R; Ballard DH; Tsai R; Naeem M; LeBlanc M; Salter A; Tsung A; Shetty AS; Borhani AA; Furlan A; Fowler KJ
Abdom Radiol (NY); 2019 Jun; 44(6):2116-2132. PubMed ID: 30798397
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.
Kim TK; Noh SY; Wilson SR; Kono Y; Piscaglia F; Jang HJ; Lyshchik A; Dietrich CF; Willmann JK; Vezeridis A; Sirlin CB
Clin Mol Hepatol; 2017 Dec; 23(4):280-289. PubMed ID: 28911220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
